ChemicalBook >> CAS DataBase List >>CIVENTICHEM CV-4057

CIVENTICHEM CV-4057

CAS No.
248281-84-7
Chemical Name:
CIVENTICHEM CV-4057
Synonyms
LAQ;CS-82;ABR 215062;ABR-215062;Lanquinimod;oro-N-ethyL;CIVENTICHEM;-2-oxo-N-phenyL;Laquinimod, >=98%;ine-3-carboxamide
CBNumber:
CB7836628
Molecular Formula:
C19H17ClN2O3
Molecular Weight:
356.8
MDL Number:
MFCD08689859
MOL File:
248281-84-7.mol
Last updated:2023-06-08 09:02:54

CIVENTICHEM CV-4057 Properties

Melting point 201 °C (decomp)
Boiling point 484.8±45.0 °C(Predicted)
Density 1.395±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
solubility Soluble in DMSO (>25 mg/ml)
form solid
pka 4.50±1.00(Predicted)
color Off-white
Stability Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
FDA UNII 908SY76S4G

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS06
Signal word  Danger
Hazard statements  H301
Precautionary statements  P301+P310
Hazard Codes  T
Risk Statements  25
Safety Statements  45
RIDADR  UN 2811 6.1 / PGIII
NFPA 704
0
3 0

CIVENTICHEM CV-4057 price More Price(57)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML2504 Laquinimod ≥98% (HPLC) 248281-84-7 10MG $40.8 2024-03-01 Buy
Sigma-Aldrich SML2504 Laquinimod ≥98% (HPLC) 248281-84-7 50MG $386 2024-03-01 Buy
Sigma-Aldrich CVT00095 5-Chloro-N-Et-4-hydroxy-1-methyl-2-oxo-N-Ph-1,2-dihydroquinoline-3-carboxamide 248281-84-7 1g $724 2024-03-01 Buy
Cayman Chemical 24187 Laquinimod ≥98% 248281-84-7 100mg $73 2024-03-01 Buy
Cayman Chemical 24187 Laquinimod ≥98% 248281-84-7 250mg $172 2024-03-01 Buy
Product number Packaging Price Buy
SML2504 10MG $40.8 Buy
SML2504 50MG $386 Buy
CVT00095 1g $724 Buy
24187 100mg $73 Buy
24187 250mg $172 Buy

CIVENTICHEM CV-4057 Chemical Properties,Uses,Production

Description

Laquinimod (248281-84-7) is an immunomodulator1 that inhibits inflammation2 and autoimmunity3,4 via activation of the aryl hydrocarbon receptor (AhR)5. It has been investigated as a treatment for multiple sclerosis6 and has shown efficacy in Huntington’s disease models7,8.

Definition

ChEBI: Laquinimod is an aromatic amide.

in vitro

abr-215062 was shown to completely inhibit the development of murine acute experimental autoimmune encephalomyelitis (eae) [1].

in vivo

abr-215062 dose-dependently inhibited disease and showed better disease inhibitory effects as compared to roquinimex (linomide). furthermore, abr-215062 inhibited the inflammation of both cd4+ t cells and macrophages into central nervous tissues [2].

References

J?nsson et al. (2004), Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders: Structure-Activity Relationship; Med. Chem. 47 2075 Rothhammer et al. (2021); Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNS, Neurol. Neuroimmunol. Neuroinflamm., 8 e946 Pitarokoili et al. (2014), Laquinimod exerts strong clinical and immunomodulatory effects in Lewis rat experimental autoimmune neuritis; Neuroimmunol., 274 38 Ott et al. (2019), Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity; Neuroinflammation, 16 49 Kaye et al. (2016), Laquinimod arrests experimental autoimmune encephalitis by activating the aryl hydrocarbon receptor; Natl. Acad. Sci. USA., 113 E6145 Th?ne and Linker (2016), Laquinimod in the treatment of multiple sclerosis: a review of the data so far; Drug Des. Devel. Ther., 10 1111 Dobson et al. (2016), Laquinimod dampens hyperactive cytokine production in Huntington’s disease patient myeloid cells; Neurochem., 137 782 Garcia-Miralles et al. (2016), Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease; Rep., 6 31652

CIVENTICHEM CV-4057 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 127)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32686 60
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873 sales@chemdad.com China 39916 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49391 58
AFINE CHEMICALS LIMITED
0571-85134551 info@afinechem.com CHINA 15377 58
Dayang Chem (Hangzhou) Co.,Ltd.
571-88938639 +8617705817739 info@dycnchem.com CHINA 52867 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
Guangzhou TongYi biochemistry technology Co.,LTD
+8613073028829 mack@tongyon.com China 2996 58
LAQ Laquinimod potassium salt 5-Chloro-N-Et-4-hydroxy-1-methyl-2-oxo-N-Ph-1,2-dihydroquinoline-3-carboxamide Laquinimod, >=98% CIVENTICHEM CV-4057 LAQUINIMOD,5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL-PHENYL-AMIDE 5-Chloro-4-hydroxy-1-Methyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid ethyl-phenyl-aMide LaquiniMod, SAIK-MS coMpound, ABR-215062 5-Chloro-4-hydroxy-1-methyl-2-oxo-N-ethyl-N-phenyl-1,2-dihydroquinoline-3-carboxamide Lanquinimod LaquiniMod,CiventicheMCV-4057,5-Chloro-4-hydroxy-1-Methyl-2-oxo-1,2-dihydroquinoline-3-carboxylicacidethylphenylaMide 5-chloro-N-ethyl-4-hydroxy-1-Methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxaMide ABR 215062 ABR-215062 LaquiniMod (ABR-215062) 5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenylquinoline-3-carboxamide -1,2-dihydroquinoL -2-oxo-N-phenyL -4-hydroxy-1-methyL ine-3-carboxamide oro-N-ethyL 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl- 5-Chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihyd... ABR-215062 (Laquinimod) CIVENTICHEM CS-82 ABR215062; ABR 215062 (LAQUINIMOD) inhibit,multiple sclerosis,relapsing remitting,carboxamide,Nuclear factor-kappaB,Apoptosis,Inhibitor,ABR 215062,Nuclear factor-κB,immunomodulator,ABR215062,chronic progressive,neurodegenerative disease,inflammation,NF-κB,Laquinimod,Orally,neurodegeneration 248281-84-7 Inhibitors api Heterocycles